Eni has freely made its supercomputing infrastructure and its molecular modelling skills available for Coronavirus research, offering its contribution with its tools and resources of excellence in the fight against this global emergency. 
 
The collaboration is part of the European EXSCALATE4CoV project, led by the biopharmaceutical company Dompé, which brings together institutions and research centres in Italy and other European countries to identify the safest and most promising drugs in the fight against the Coronavirus. Eni contributes to the project in partnership with Cineca, a non-profit research consortium that involves the collaboration of universities, national research centres and the Italian Ministry of Education, University and Research. 
La collaborazione è un'importante esempio di aggregazione di risorse, in un contesto di emergenza globale.

More information in Eni's press release.

The consortium il leaded by Dompé farmaceutici and gathers 18 Institutions and research centers in 7 Europeans Countries: Politecnico di Milano (Dipartimento di Elettronica, Informazione e Bioingegneria), Consorzio Interuniversitario CINECA (Supercomputing Innovation and Applications), Università degli Studi di Milano (Dipartimento di Scienze Farmaceutiche), Katholieke Universiteit Leuven, International Institute Of Molecular And Cell Biology In Warsaw (LIMCB), Elettra - Sincrotrone Trieste, Fraunhofer Institute for Molecular Biology and Applied Ecology, Bsc Supercomputing Centre, Forschungszentrum Jülich, Università Federico II di Napoli, Università degli Studi di Cagliari, SIB Swiss Institute of Bioinformatics, KTH Royal Institute of Technology(Department of Applied Physics), Associazione BigData, Istituto Nazionale Di Fisica Nucleare (INFN), l’Istituto nazionale per le malattie infettive Lazzaro Spallanzani e Chelonia Applied Science.